Daicel stock enters a semiconductor materials joint venture

Daicel (ISIN JP3485800001) was trading at JPY 1,444 on the Tokyo Stock Exchange on October 8, 2026 at 11:30 a.m. JST, down 1.13 percent from the prior close of JPY 1,460.50. The company also gained a new semiconductor materials growth angle after ChemLOCUS reported the planned Formosa and Daicel joint venture on October 2, 2026.

Joint venture targets semiconductors

The project is set to include a plant in Kaohsiung, Taiwan, with production of photoresist thinners planned by the end of 2028, ChemLOCUS reported. The planned capacity buildout gives Daicel exposure to semiconductor materials, but the project remains a future operating opportunity rather than a current earnings contribution.

Q1 revenue beats the estimate

Daicel's Q1 FY2027 revenue was JPY 152.38 billion and earnings were JPY 9.36 billion, according to Yahoo Finance. The revenue figure exceeded the JPY 144.05 billion estimate by 5.8 percent, while the latest announcement was dated July 31, 2026, Investing.com reported.

Consensus stays Neutral

The analyst consensus is Neutral, based on eight analysts with one Buy, five Hold and two Sell ratings, according to Investing.com. The average 12-month target is JPY 1,513.8, with a low of JPY 1,260 and a high of JPY 2,400; the average target lies 4.8 percent above the October 8 price.

Chiral columns add a second angle

Daicel's chiral columns separate enantiomers used in pharmaceutical research and manufacturing, while the company provides related services in Japan, China, India, France and the United States, Asset Alive reported on October 7, 2026. That business connection to pharmaceutical quality gives the semiconductor project a separate growth narrative from Daicel's established specialty-chemicals operations.

Market value and yearly range

Daicel's market capitalization was JPY 368.8 billion on October 8, 2026, with 418,000 shares traded. The 52-week range was JPY 1,112.50 to JPY 1,658, placing the latest quote 12.9 percent below the high.

Upcoming dates for Daicel stock

• November 5, 2026: Q2 FY2027 earnings release

More news and analyses on Daicel stock